Evaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis

References

1. ↵
   1. World Health Organization

   (2014) Global tuberculosis report. World Health Organization (Geneva).
2. ↵
   1. El Din MAT,
   2. El Maraghy AA,
   3. Hay AHRA

   (2015) Adverse reactions among patients being treated for multi-drug resistant tuberculosis at Abbassia Chest Hospital. Egyptian Journal of Chest Diseases and Tuberculosis 64:939–952.

   OpenUrl
3. ↵
   1. Zar HJ,
   2. Workman L,
   3. Isaacs W,
   4. Munro J,
   5. Black F,
   6. Eley B,
   7. et al.

   (2012) Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis 55:1088–1095.

   OpenUrlCrossRefPubMed
4. ↵
   1. Zeka AN,
   2. Tasbakan S,
   3. Cavusoglu C

   (2011) Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. J Clinical Microbiol 49:4138–4141.

   OpenUrlAbstract/FREE Full Text
5. ↵
   1. Kivihya-Ndugga LE,
   2. van Cleeff MR,
   3. Githui WA,
   4. Nganga LW,
   5. Kibuga DK,
   6. Odhiambo JA,
   7. et al.

   (2003) A comprehensive comparison of Ziehl-Neelsen and fluorescence microscopy for the diagnosis of tuberculosis in a resource-poor urban setting. Int J Tuberc Lung Dis 7:1163–1171.

   OpenUrlPubMedWeb of Science
6. ↵
   1. Lawn SD,
   2. Brooks SV,
   3. Kranzer K,
   4. Nicol MP,
   5. Whitelaw A,
   6. Vogt M,
   7. et al.

   (2011) Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Medi 8:e1001067.

   OpenUrl
7. ↵
   1. O’Grady J,
   2. Maeurer M,
   3. Mwaba P,
   4. Kapata N,
   5. Bates M,
   6. Hoelscher M,
   7. et al.

   (2011) New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. Curr Opin Pulm Med 17:134–141.

   OpenUrlCrossRefPubMed
8. ↵
   1. Boehme CC,
   2. Nabeta P,
   3. Hillemann D,
   4. Nicol MP,
   5. Shenai S,
   6. Krapp F,
   7. et al.

   (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363:1005–1015.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Helb D,
   2. Jones M,
   3. Story E,
   4. Boehme C,
   5. Wallace E,
   6. Ho K,
   7. et al.

   (2010) Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 48:229–237.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Boehme CC,
    2. Nicol MP,
    3. Nabeta P,
    4. Michael JS,
    5. Gotuzzo E,
    6. Tahirli R,
    7. et al.

    (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377:1495–1505.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Steingart KR,
    2. Schiller I,
    3. Horne DJ,
    4. Pai M,
    5. Boehme CC,
    6. Dendukuri N

    (2014) Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev (1):CD009593.
12. ↵
    1. Reither K,
    2. Manyama C,
    3. Clowes P,
    4. Rachow A,
    5. Mapamba D,
    6. Steiner A,
    7. et al.

    (2015) Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: a prospective, multi-centre evaluation. J Infect 70:392–399.

    OpenUrlCrossRef
13. ↵
    1. Deggim V,
    2. Somoskovi A,
    3. Voit A,
    4. Böttger EC,
    5. Bloemberg GV

    (2013) Integrating the Xpert MTB/RIF assay into a diagnostic workflow for rapid detection of Mycobacterium tuberculosis in a low-prevalence area. J Clin Microbiol 51:2396–2369.

    OpenUrlAbstract/FREE Full Text
14. ↵
    1. Tortoli E,
    2. Russo C,
    3. Piersimoni C,
    4. Mazzola E,
    5. Dal Monte P,
    6. Pascarella M,
    7. et al.

    (2012) Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 40:442–447.

    OpenUrlAbstract/FREE Full Text
15. ↵
    1. Graham SM,
    2. Ahmed T,
    3. Amanullah F,
    4. Browning R,
    5. Cardenas V,
    6. Casenghi M,
    7. et al.

    (2012) Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis 205(Suppl2):S199–S208.

    OpenUrlCrossRefPubMed
16. ↵
    1. Zar HJ,
    2. Hanslo D,
    3. Apolles P,
    4. Swingler G,
    5. Hussey G

    (2005) Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 365:130–134.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Kawai V,
    2. Soto G,
    3. Gilman RH,
    4. Bautista CT,
    5. Caviedes L,
    6. Huaroto L,
    7. et al.

    (2006) Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg 75:1027–1033.

    OpenUrlAbstract/FREE Full Text
18. ↵
    1. Kent PT,
    2. Kubica GP

    (1985) Public health mycobacteriology: a guide for the level III laboratory (US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta (GA)).
19. ↵
    1. Swets JA,
    2. Pickett RM

    (1982) Evaluation of diagnostic systems: methods from signal detection theory (Academic Press, New York (NY)).
20. ↵
    1. Bunsow E,
    2. Ruiz-Serrano MJ,
    3. Lopez Roa P,
    4. Kestler M,
    5. Viedma DG,
    6. Bouza E

    (2014) Evaluation of GeneXpert MTB/RIF for the detection of Mycobacterium tuberculosis and resistance to rifampin in clinical specimens. J Infect 68:338–343.

    OpenUrlCrossRefPubMed
21. ↵
    1. Zmak L,
    2. Jankovic M,
    3. Jankovic VK

    (2013) Evaluation of Xpert MTB/RIF assay for rapid molecular diagnosis of tuberculosis in a two-year period in Croatia. Int J Mycobacteriol 2:179–182.

    OpenUrl
22. ↵
    1. Steingart KR,
    2. Ng V,
    3. Henry M,
    4. Hopewell PC,
    5. Ramsay A,
    6. Cunningham J,
    7. et al.

    (2006) Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 6:664–674.

    OpenUrlCrossRefPubMedWeb of Science
23. ↵
    1. Marlowe EM,
    2. Novak-Weekley SM,
    3. Cumpio J,
    4. Sharp SE,
    5. Momeny MA,
    6. Babst A,
    7. et al.

    (2011) Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol 49:1621–163.

    OpenUrlAbstract/FREE Full Text
24. ↵
    1. Rachow A,
    2. Clowes P,
    3. Saathoff E,
    4. Mtafya B,
    5. Michael E,
    6. Ntinginya EN,
    7. et al.

    (2012) Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study. Clin Infect Dis 54:1388–1396.

    OpenUrlCrossRefPubMed
25. ↵
    1. Sekadde MP,
    2. Wobudeya E,
    3. Joloba ML,
    4. Ssengooba W,
    5. Kisembo H,
    6. Bakeera-Kitaka S,
    7. et al.

    (2013) Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic study. BMC Infect Dis 13:133.

    OpenUrlCrossRefPubMed
26. ↵
    1. Moure R,
    2. Muñoz L,
    3. Torres M,
    4. Santin M,
    5. Martín R,
    6. Alcaide F

    (2011) Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method. J Clin Microbiol 49:1137–1139.

    OpenUrlAbstract/FREE Full Text
27. ↵
    1. Nicol MP,
    2. Workman L,
    3. Isaacs W,
    4. Munro J,
    5. Black F,
    6. Eley B,
    7. et al.

    (2011) Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 11:819–824.

    OpenUrlCrossRefPubMedWeb of Science